162 related articles for article (PubMed ID: 15621665)
21. Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4.
Ohnishi A; Matsuo H; Yamada S; Takanaga H; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
Br J Pharmacol; 2000 Jul; 130(6):1369-77. PubMed ID: 10903978
[TBL] [Abstract][Full Text] [Related]
22. Calcitriol regulates the expression of the genes encoding the three key vitamin D3 hydroxylases and the drug-metabolizing enzyme CYP3A4 in the human fetal intestine.
Theodoropoulos C; Demers C; Delvin E; Ménard D; Gascon-Barré M
Clin Endocrinol (Oxf); 2003 Apr; 58(4):489-99. PubMed ID: 12641633
[TBL] [Abstract][Full Text] [Related]
23. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity.
Patel J; Buddha B; Dey S; Pal D; Mitra AK
Am J Ther; 2004; 11(4):262-77. PubMed ID: 15266218
[TBL] [Abstract][Full Text] [Related]
24. Involvement of CYP3A4 and MDR1 in altered metabolism and transport of indinavir in 1,25(OH)
Lee SJ; Joo SA; Kim H; Lee Y; Chung SJ; Chae YJ; Maeng HJ
Eur J Pharm Sci; 2023 Apr; 183():106396. PubMed ID: 36736464
[TBL] [Abstract][Full Text] [Related]
25. Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5.
Mouly SJ; Matheny C; Paine MF; Smith G; Lamba J; Lamba V; Pusek SN; Schuetz EG; Stewart PW; Watkins PB
Clin Pharmacol Ther; 2005 Dec; 78(6):605-18. PubMed ID: 16338276
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells.
Takanaga H; Ohnishi A; Matsuo H; Sawada Y
Biol Pharm Bull; 1998 Oct; 21(10):1062-6. PubMed ID: 9821810
[TBL] [Abstract][Full Text] [Related]
27. Measurement of hepatic and intestinal CYP3A4 and PGP activity by combined po + iv [14C]erythromycin breath and urine test.
Lemahieu WP; Maes BD; Ghoos Y; Rutgeerts P; Verbeke K; Vanrenterghem Y
Am J Physiol Gastrointest Liver Physiol; 2003 Sep; 285(3):G470-82. PubMed ID: 12909563
[TBL] [Abstract][Full Text] [Related]
28. Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein.
Ushigome F; Takanaga H; Matsuo H; Yanai S; Tsukimori K; Nakano H; Uchiumi T; Nakamura T; Kuwano M; Ohtani H; Sawada Y
Eur J Pharmacol; 2000 Nov; 408(1):1-10. PubMed ID: 11070177
[TBL] [Abstract][Full Text] [Related]
29. Modulation of human cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp) in Caco-2 cell monolayers by selected commercial-source milk thistle and goldenseal products.
Budzinski JW; Trudeau VL; Drouin CE; Panahi M; Arnason JT; Foster BC
Can J Physiol Pharmacol; 2007 Sep; 85(9):966-78. PubMed ID: 18066144
[TBL] [Abstract][Full Text] [Related]
30. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
[TBL] [Abstract][Full Text] [Related]
31. Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats.
Kalitsky-Szirtes J; Shayeganpour A; Brocks DR; Piquette-Miller M
Drug Metab Dispos; 2004 Jan; 32(1):20-7. PubMed ID: 14709616
[TBL] [Abstract][Full Text] [Related]
32. The effects of culture conditions on CYP3A4 and MDR1 mRNA induction by 1alpha,25-dihydroxyvitamin D(3) in human intestinal cell lines, Caco-2 and LS180.
Aiba T; Susa M; Fukumori S; Hashimoto Y
Drug Metab Pharmacokinet; 2005 Aug; 20(4):268-74. PubMed ID: 16141606
[TBL] [Abstract][Full Text] [Related]
33. C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation.
Goto M; Masuda S; Saito H; Uemoto S; Kiuchi T; Tanaka K; Inui K
Pharmacogenetics; 2002 Aug; 12(6):451-7. PubMed ID: 12172213
[TBL] [Abstract][Full Text] [Related]
34. Abiraterone inhibits 1α,25-dihydroxyvitamin D3 metabolism by CYP3A4 in human liver and intestine in vitro.
Deb S; Chin MY; Adomat H; Guns ES
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():50-8. PubMed ID: 24269662
[TBL] [Abstract][Full Text] [Related]
35. N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs.
Brandes LJ; Queen GM; LaBella FS
Cancer Chemother Pharmacol; 2000; 45(4):298-304. PubMed ID: 10755318
[TBL] [Abstract][Full Text] [Related]
36. Rifampin and digoxin induction of MDR1 expression and function in human intestinal (T84) epithelial cells.
Haslam IS; Jones K; Coleman T; Simmons NL
Br J Pharmacol; 2008 May; 154(1):246-55. PubMed ID: 18332862
[TBL] [Abstract][Full Text] [Related]
37. CYP1A1 induction and CYP3A4 inhibition by the fungicide imazalil in the human intestinal Caco-2 cells-comparison with other conazole pesticides.
Sergent T; Dupont I; Jassogne C; Ribonnet L; van der Heiden E; Scippo ML; Muller M; McAlister D; Pussemier L; Larondelle Y; Schneider YJ
Toxicol Lett; 2009 Feb; 184(3):159-68. PubMed ID: 19070657
[TBL] [Abstract][Full Text] [Related]
38. Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells.
Cavet ME; West M; Simmons NL
Br J Pharmacol; 1996 Jul; 118(6):1389-96. PubMed ID: 8832062
[TBL] [Abstract][Full Text] [Related]
39. Cytokines influence mRNA expression of cytochrome P450 3A4 and MDRI in intestinal cells.
Bertilsson PM; Olsson P; Magnusson KE
J Pharm Sci; 2001 May; 90(5):638-46. PubMed ID: 11288108
[TBL] [Abstract][Full Text] [Related]
40. Alterations of CYP3A4 and P-glycoprotein activity in vivo with time in renal graft recipients.
Lemahieu WP; Maes BD; Verbeke K; Vanrenterghem YF
Kidney Int; 2004 Jul; 66(1):433-40. PubMed ID: 15200453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
